Obalon Therapeutics, Inc.

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, ABT has a market cap of 178.3B. Regarding current trading prices, OBLN is priced at $3.05, while ABT trades at $103.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas ABT's P/E ratio is 28.11. In terms of profitability, OBLN's ROE is -2.78%, compared to ABT's ROE of +0.13%. Regarding short-term risk, OBLN is more volatile compared to ABT. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check ABT's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, OBLN is priced at $3.05, while BSX-PA trades at $122.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, OBLN's ROE is -2.78%, compared to BSX-PA's ROE of +0.13%. Regarding short-term risk, OBLN is more volatile compared to BSX-PA. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check BSX-PA's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, SYK has a market cap of 125.7B. Regarding current trading prices, OBLN is priced at $3.05, while SYK trades at $329.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas SYK's P/E ratio is 39.07. In terms of profitability, OBLN's ROE is -2.78%, compared to SYK's ROE of +0.15%. Regarding short-term risk, OBLN is more volatile compared to SYK. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check SYK's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, MDT has a market cap of 111.2B. Regarding current trading prices, OBLN is priced at $3.05, while MDT trades at $86.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas MDT's P/E ratio is 24.61. In terms of profitability, OBLN's ROE is -2.78%, compared to MDT's ROE of +0.10%. Regarding short-term risk, OBLN is more volatile compared to MDT. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check MDT's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, BSX has a market cap of 93.1B. Regarding current trading prices, OBLN is priced at $3.05, while BSX trades at $62.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas BSX's P/E ratio is 32.33. In terms of profitability, OBLN's ROE is -2.78%, compared to BSX's ROE of +0.13%. Regarding short-term risk, OBLN is more volatile compared to BSX. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check BSX's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, EW has a market cap of 46.5B. Regarding current trading prices, OBLN is priced at $3.05, while EW trades at $81.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas EW's P/E ratio is 44.25. In terms of profitability, OBLN's ROE is -2.78%, compared to EW's ROE of +0.10%. Regarding short-term risk, OBLN is more volatile compared to EW. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check EW's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, BRKRP has a market cap of 43.6B. Regarding current trading prices, OBLN is priced at $3.05, while BRKRP trades at $290.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas BRKRP's P/E ratio is N/A. In terms of profitability, OBLN's ROE is -2.78%, compared to BRKRP's ROE of -0.00%. Regarding short-term risk, OBLN is more volatile compared to BRKRP. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check BRKRP's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, PHG has a market cap of 26.3B. Regarding current trading prices, OBLN is priced at $3.05, while PHG trades at $27.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas PHG's P/E ratio is 25.61. In terms of profitability, OBLN's ROE is -2.78%, compared to PHG's ROE of +0.08%. Regarding short-term risk, OBLN is more volatile compared to PHG. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check PHG's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, DXCM has a market cap of 24.5B. Regarding current trading prices, OBLN is priced at $3.05, while DXCM trades at $63.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas DXCM's P/E ratio is 30.05. In terms of profitability, OBLN's ROE is -2.78%, compared to DXCM's ROE of +0.32%. Regarding short-term risk, OBLN is more volatile compared to DXCM. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check DXCM's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, STE has a market cap of 21.7B. Regarding current trading prices, OBLN is priced at $3.05, while STE trades at $220.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas STE's P/E ratio is 30.84. In terms of profitability, OBLN's ROE is -2.78%, compared to STE's ROE of +0.10%. Regarding short-term risk, OBLN is more volatile compared to STE. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check STE's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, ZBH has a market cap of 17.9B. Regarding current trading prices, OBLN is priced at $3.05, while ZBH trades at $90.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas ZBH's P/E ratio is 25.47. In terms of profitability, OBLN's ROE is -2.78%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, OBLN is more volatile compared to ZBH. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check ZBH's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, OBLN is priced at $3.05, while ABMD trades at $381.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas ABMD's P/E ratio is 65.36. In terms of profitability, OBLN's ROE is -2.78%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, OBLN is more volatile compared to ABMD. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check ABMD's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, PODD has a market cap of 14.8B. Regarding current trading prices, OBLN is priced at $3.05, while PODD trades at $208.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas PODD's P/E ratio is 60.47. In terms of profitability, OBLN's ROE is -2.78%, compared to PODD's ROE of +0.17%. Regarding short-term risk, OBLN is more volatile compared to PODD. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check PODD's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, SNN has a market cap of 13.5B. Regarding current trading prices, OBLN is priced at $3.05, while SNN trades at $32.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas SNN's P/E ratio is 22.24. In terms of profitability, OBLN's ROE is -2.78%, compared to SNN's ROE of +0.12%. Regarding short-term risk, OBLN is more volatile compared to SNN. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check SNN's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, PEN has a market cap of 12.9B. Regarding current trading prices, OBLN is priced at $3.05, while PEN trades at $329.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas PEN's P/E ratio is 72.47. In terms of profitability, OBLN's ROE is -2.78%, compared to PEN's ROE of +0.13%. Regarding short-term risk, OBLN is more volatile compared to PEN. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check PEN's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, OBLN is priced at $3.05, while SWAV trades at $334.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas SWAV's P/E ratio is 78.76. In terms of profitability, OBLN's ROE is -2.78%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, OBLN is more volatile compared to SWAV. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check SWAV's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, ALGN has a market cap of 12.3B. Regarding current trading prices, OBLN is priced at $3.05, while ALGN trades at $176.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas ALGN's P/E ratio is 30.28. In terms of profitability, OBLN's ROE is -2.78%, compared to ALGN's ROE of +0.10%. Regarding short-term risk, OBLN is more volatile compared to ALGN. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check ALGN's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, GMED has a market cap of 11.7B. Regarding current trading prices, OBLN is priced at $3.05, while GMED trades at $87.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas GMED's P/E ratio is 21.98. In terms of profitability, OBLN's ROE is -2.78%, compared to GMED's ROE of +0.12%. Regarding short-term risk, OBLN is more volatile compared to GMED. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check GMED's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, BIO has a market cap of 7.5B. Regarding current trading prices, OBLN is priced at $3.05, while BIO trades at $281.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas BIO's P/E ratio is 10.02. In terms of profitability, OBLN's ROE is -2.78%, compared to BIO's ROE of +0.11%. Regarding short-term risk, OBLN is more volatile compared to BIO. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check BIO's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, BIO-B has a market cap of 7.5B. Regarding current trading prices, OBLN is priced at $3.05, while BIO-B trades at $278.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas BIO-B's P/E ratio is 9.99. In terms of profitability, OBLN's ROE is -2.78%, compared to BIO-B's ROE of +0.11%. Regarding short-term risk, OBLN is more volatile compared to BIO-B. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check BIO-B's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, GKOS has a market cap of 6.3B. Regarding current trading prices, OBLN is priced at $3.05, while GKOS trades at $113.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas GKOS's P/E ratio is -32.83. In terms of profitability, OBLN's ROE is -2.78%, compared to GKOS's ROE of -0.25%. Regarding short-term risk, OBLN is more volatile compared to GKOS. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check GKOS's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, BRKR has a market cap of 5.5B. Regarding current trading prices, OBLN is priced at $3.05, while BRKR trades at $36.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas BRKR's P/E ratio is -240.80. In terms of profitability, OBLN's ROE is -2.78%, compared to BRKR's ROE of -0.00%. Regarding short-term risk, OBLN is more volatile compared to BRKR. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check BRKR's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, OBLN is priced at $3.05, while NARI trades at $79.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas NARI's P/E ratio is -59.24. In terms of profitability, OBLN's ROE is -2.78%, compared to NARI's ROE of -0.00%. Regarding short-term risk, OBLN is more volatile compared to NARI. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check NARI's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, IRTC has a market cap of 3.8B. Regarding current trading prices, OBLN is priced at $3.05, while IRTC trades at $119.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas IRTC's P/E ratio is -84.91. In terms of profitability, OBLN's ROE is -2.78%, compared to IRTC's ROE of -0.38%. Regarding short-term risk, OBLN is more volatile compared to IRTC. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check IRTC's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, OBLN is priced at $3.05, while AXNX trades at $70.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas AXNX's P/E ratio is -709.80. In terms of profitability, OBLN's ROE is -2.78%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, OBLN is more volatile compared to AXNX. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check AXNX's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, LIVN has a market cap of 3.5B. Regarding current trading prices, OBLN is priced at $3.05, while LIVN trades at $64.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas LIVN's P/E ratio is -14.28. In terms of profitability, OBLN's ROE is -2.78%, compared to LIVN's ROE of -0.21%. Regarding short-term risk, OBLN is more volatile compared to LIVN. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check LIVN's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, TMDX has a market cap of 3.4B. Regarding current trading prices, OBLN is priced at $3.05, while TMDX trades at $101.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas TMDX's P/E ratio is 20.41. In terms of profitability, OBLN's ROE is -2.78%, compared to TMDX's ROE of +0.54%. Regarding short-term risk, OBLN is more volatile compared to TMDX. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check TMDX's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, ITGR has a market cap of 3.1B. Regarding current trading prices, OBLN is priced at $3.05, while ITGR trades at $88.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas ITGR's P/E ratio is 30.45. In terms of profitability, OBLN's ROE is -2.78%, compared to ITGR's ROE of +0.06%. Regarding short-term risk, OBLN is more volatile compared to ITGR. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check ITGR's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, OBLN is priced at $3.05, while NUVA trades at $39.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas NUVA's P/E ratio is 75.00. In terms of profitability, OBLN's ROE is -2.78%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, OBLN is more volatile compared to NUVA. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check NUVA's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, AORT has a market cap of 1.8B. Regarding current trading prices, OBLN is priced at $3.05, while AORT trades at $35.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas AORT's P/E ratio is 174.37. In terms of profitability, OBLN's ROE is -2.78%, compared to AORT's ROE of +0.02%. Regarding short-term risk, OBLN is more volatile compared to AORT. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check AORT's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, AXGN has a market cap of 1.7B. Regarding current trading prices, OBLN is priced at $3.05, while AXGN trades at $33.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas AXGN's P/E ratio is -97.44. In terms of profitability, OBLN's ROE is -2.78%, compared to AXGN's ROE of -0.13%. Regarding short-term risk, OBLN is more volatile compared to AXGN. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check AXGN's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, ESTA has a market cap of 1.7B. Regarding current trading prices, OBLN is priced at $3.05, while ESTA trades at $58.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas ESTA's P/E ratio is -33.01. In terms of profitability, OBLN's ROE is -2.78%, compared to ESTA's ROE of -2.02%. Regarding short-term risk, OBLN is more volatile compared to ESTA. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check ESTA's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, ATEC has a market cap of 1.6B. Regarding current trading prices, OBLN is priced at $3.05, while ATEC trades at $11.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas ATEC's P/E ratio is -11.33. In terms of profitability, OBLN's ROE is -2.78%, compared to ATEC's ROE of -17.60%. Regarding short-term risk, OBLN is more volatile compared to ATEC. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check ATEC's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, AHCO has a market cap of 1.6B. Regarding current trading prices, OBLN is priced at $3.05, while AHCO trades at $11.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas AHCO's P/E ratio is -22.82. In terms of profitability, OBLN's ROE is -2.78%, compared to AHCO's ROE of -0.05%. Regarding short-term risk, OBLN is more volatile compared to AHCO. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check AHCO's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, PMI has a market cap of 1.6B. Regarding current trading prices, OBLN is priced at $3.05, while PMI trades at $1.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas PMI's P/E ratio is -2.02. In terms of profitability, OBLN's ROE is -2.78%, compared to PMI's ROE of +2.17%. Regarding short-term risk, OBLN is more volatile compared to PMI. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check PMI's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, UFPT has a market cap of 1.5B. Regarding current trading prices, OBLN is priced at $3.05, while UFPT trades at $197.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas UFPT's P/E ratio is 22.13. In terms of profitability, OBLN's ROE is -2.78%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, OBLN is more volatile compared to UFPT. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check UFPT's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, INSP has a market cap of 1.5B. Regarding current trading prices, OBLN is priced at $3.05, while INSP trades at $52.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas INSP's P/E ratio is 10.56. In terms of profitability, OBLN's ROE is -2.78%, compared to INSP's ROE of +0.21%. Regarding short-term risk, OBLN is more volatile compared to INSP. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check INSP's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, PRCT has a market cap of 1.4B. Regarding current trading prices, OBLN is priced at $3.05, while PRCT trades at $25.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas PRCT's P/E ratio is -14.53. In terms of profitability, OBLN's ROE is -2.78%, compared to PRCT's ROE of -0.25%. Regarding short-term risk, OBLN is more volatile compared to PRCT. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check PRCT's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, TNDM has a market cap of 1.3B. Regarding current trading prices, OBLN is priced at $3.05, while TNDM trades at $19.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas TNDM's P/E ratio is -6.31. In terms of profitability, OBLN's ROE is -2.78%, compared to TNDM's ROE of -1.42%. Regarding short-term risk, OBLN is more volatile compared to TNDM. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check TNDM's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, OBLN is priced at $3.05, while HSKA trades at $119.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas HSKA's P/E ratio is -62.49. In terms of profitability, OBLN's ROE is -2.78%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, OBLN is more volatile compared to HSKA. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check HSKA's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, IRMD has a market cap of 1.2B. Regarding current trading prices, OBLN is priced at $3.05, while IRMD trades at $96.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas IRMD's P/E ratio is 55.01. In terms of profitability, OBLN's ROE is -2.78%, compared to IRMD's ROE of +0.24%. Regarding short-term risk, OBLN is more volatile compared to IRMD. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check IRMD's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, OBLN is priced at $3.05, while SILK trades at $27.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas SILK's P/E ratio is -18.96. In terms of profitability, OBLN's ROE is -2.78%, compared to SILK's ROE of -0.35%. Regarding short-term risk, OBLN is more volatile compared to SILK. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check SILK's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, OBLN is priced at $3.05, while FNA trades at $13.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas FNA's P/E ratio is -19.83. In terms of profitability, OBLN's ROE is -2.78%, compared to FNA's ROE of -0.17%. Regarding short-term risk, OBLN is more volatile compared to FNA. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check FNA's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, CNMD has a market cap of 1.1B. Regarding current trading prices, OBLN is priced at $3.05, while CNMD trades at $36.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas CNMD's P/E ratio is 23.40. In terms of profitability, OBLN's ROE is -2.78%, compared to CNMD's ROE of +0.05%. Regarding short-term risk, OBLN is more volatile compared to CNMD. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check CNMD's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, BFLY has a market cap of 1B. Regarding current trading prices, OBLN is priced at $3.05, while BFLY trades at $4.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas BFLY's P/E ratio is -13.02. In terms of profitability, OBLN's ROE is -2.78%, compared to BFLY's ROE of -0.35%. Regarding short-term risk, OBLN is more volatile compared to BFLY. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check BFLY's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, SSII has a market cap of 971.8M. Regarding current trading prices, OBLN is priced at $3.05, while SSII trades at $5.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas SSII's P/E ratio is -83.33. In terms of profitability, OBLN's ROE is -2.78%, compared to SSII's ROE of -0.30%. Regarding short-term risk, OBLN is more volatile compared to SSII. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check SSII's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, INMD has a market cap of 866.7M. Regarding current trading prices, OBLN is priced at $3.05, while INMD trades at $13.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas INMD's P/E ratio is 9.57. In terms of profitability, OBLN's ROE is -2.78%, compared to INMD's ROE of +0.15%. Regarding short-term risk, OBLN is more volatile compared to INMD. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check INMD's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, CSII has a market cap of 844M. Regarding current trading prices, OBLN is priced at $3.05, while CSII trades at $20.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas CSII's P/E ratio is -20.83. In terms of profitability, OBLN's ROE is -2.78%, compared to CSII's ROE of -0.14%. Regarding short-term risk, OBLN is more volatile compared to CSII. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check CSII's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, LMRI has a market cap of 813.3M. Regarding current trading prices, OBLN is priced at $3.05, while LMRI trades at $9.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas LMRI's P/E ratio is -18.70. In terms of profitability, OBLN's ROE is -2.78%, compared to LMRI's ROE of -0.18%. Regarding short-term risk, OBLN is more volatile compared to LMRI. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check LMRI's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, IART has a market cap of 734.2M. Regarding current trading prices, OBLN is priced at $3.05, while IART trades at $9.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas IART's P/E ratio is -1.40. In terms of profitability, OBLN's ROE is -2.78%, compared to IART's ROE of -0.44%. Regarding short-term risk, OBLN is more volatile compared to IART. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check IART's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, CRY has a market cap of 725.1M. Regarding current trading prices, OBLN is priced at $3.05, while CRY trades at $17.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas CRY's P/E ratio is 425.71. In terms of profitability, OBLN's ROE is -2.78%, compared to CRY's ROE of +0.02%. Regarding short-term risk, OBLN is more volatile compared to CRY. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check CRY's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, CBLL has a market cap of 690M. Regarding current trading prices, OBLN is priced at $3.05, while CBLL trades at $18.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas CBLL's P/E ratio is -12.55. In terms of profitability, OBLN's ROE is -2.78%, compared to CBLL's ROE of -0.32%. Regarding short-term risk, OBLN is more volatile compared to CBLL. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check CBLL's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, AVNS has a market cap of 651.7M. Regarding current trading prices, OBLN is priced at $3.05, while AVNS trades at $14.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas AVNS's P/E ratio is -8.93. In terms of profitability, OBLN's ROE is -2.78%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, OBLN is more volatile compared to AVNS. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check AVNS's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, BVS has a market cap of 615.1M. Regarding current trading prices, OBLN is priced at $3.05, while BVS trades at $9.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas BVS's P/E ratio is 27.67. In terms of profitability, OBLN's ROE is -2.78%, compared to BVS's ROE of +0.14%. Regarding short-term risk, OBLN is more volatile compared to BVS. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check BVS's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, OBLN is priced at $3.05, while SRDX trades at $42.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas SRDX's P/E ratio is -34.66. In terms of profitability, OBLN's ROE is -2.78%, compared to SRDX's ROE of -0.16%. Regarding short-term risk, OBLN is more volatile compared to SRDX. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check SRDX's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, TCMD has a market cap of 594.5M. Regarding current trading prices, OBLN is priced at $3.05, while TCMD trades at $26.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas TCMD's P/E ratio is 31.87. In terms of profitability, OBLN's ROE is -2.78%, compared to TCMD's ROE of +0.09%. Regarding short-term risk, OBLN is more volatile compared to TCMD. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check TCMD's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, OBLN is priced at $3.05, while APEN trades at $10.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas APEN's P/E ratio is -9.43. In terms of profitability, OBLN's ROE is -2.78%, compared to APEN's ROE of -0.85%. Regarding short-term risk, OBLN is more volatile compared to APEN. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check APEN's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, CTKB has a market cap of 561.8M. Regarding current trading prices, OBLN is priced at $3.05, while CTKB trades at $4.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas CTKB's P/E ratio is -8.40. In terms of profitability, OBLN's ROE is -2.78%, compared to CTKB's ROE of -0.18%. Regarding short-term risk, OBLN is more volatile compared to CTKB. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check CTKB's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, SIBN has a market cap of 557.8M. Regarding current trading prices, OBLN is priced at $3.05, while SIBN trades at $12.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas SIBN's P/E ratio is -28.70. In terms of profitability, OBLN's ROE is -2.78%, compared to SIBN's ROE of -0.11%. Regarding short-term risk, OBLN is more volatile compared to SIBN. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check SIBN's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, OBLN is priced at $3.05, while ZIMV trades at $18.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, OBLN's ROE is -2.78%, compared to ZIMV's ROE of -0.05%. Regarding short-term risk, OBLN is more volatile compared to ZIMV. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check ZIMV's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, BWAY has a market cap of 521.3M. Regarding current trading prices, OBLN is priced at $3.05, while BWAY trades at $13.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas BWAY's P/E ratio is 73.83. In terms of profitability, OBLN's ROE is -2.78%, compared to BWAY's ROE of +0.11%. Regarding short-term risk, OBLN is more volatile compared to BWAY. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check BWAY's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, OFIX has a market cap of 460.5M. Regarding current trading prices, OBLN is priced at $3.05, while OFIX trades at $11.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas OFIX's P/E ratio is -4.92. In terms of profitability, OBLN's ROE is -2.78%, compared to OFIX's ROE of -0.20%. Regarding short-term risk, OBLN is more volatile compared to OFIX. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check OFIX's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, VREX has a market cap of 444.8M. Regarding current trading prices, OBLN is priced at $3.05, while VREX trades at $10.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas VREX's P/E ratio is -6.47. In terms of profitability, OBLN's ROE is -2.78%, compared to VREX's ROE of -0.14%. Regarding short-term risk, OBLN is more volatile compared to VREX. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check VREX's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, NPCE has a market cap of 442.7M. Regarding current trading prices, OBLN is priced at $3.05, while NPCE trades at $14.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas NPCE's P/E ratio is -19.92. In terms of profitability, OBLN's ROE is -2.78%, compared to NPCE's ROE of -1.06%. Regarding short-term risk, OBLN is more volatile compared to NPCE. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check NPCE's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, KIDS has a market cap of 401.2M. Regarding current trading prices, OBLN is priced at $3.05, while KIDS trades at $16.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas KIDS's P/E ratio is -9.39. In terms of profitability, OBLN's ROE is -2.78%, compared to KIDS's ROE of -0.11%. Regarding short-term risk, OBLN is more volatile compared to KIDS. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check KIDS's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, PACB has a market cap of 398.6M. Regarding current trading prices, OBLN is priced at $3.05, while PACB trades at $1.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas PACB's P/E ratio is -0.73. In terms of profitability, OBLN's ROE is -2.78%, compared to PACB's ROE of -11.23%. Regarding short-term risk, OBLN is more volatile compared to PACB. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check PACB's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, LAB has a market cap of 358.6M. Regarding current trading prices, OBLN is priced at $3.05, while LAB trades at $0.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas LAB's P/E ratio is -6.13. In terms of profitability, OBLN's ROE is -2.78%, compared to LAB's ROE of -0.18%. Regarding short-term risk, OBLN is more volatile compared to LAB. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check LAB's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, VMD has a market cap of 355.5M. Regarding current trading prices, OBLN is priced at $3.05, while VMD trades at $9.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas VMD's P/E ratio is 24.89. In terms of profitability, OBLN's ROE is -2.78%, compared to VMD's ROE of +0.11%. Regarding short-term risk, OBLN is more volatile compared to VMD. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check VMD's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, CERS has a market cap of 349.8M. Regarding current trading prices, OBLN is priced at $3.05, while CERS trades at $1.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas CERS's P/E ratio is -22.75. In terms of profitability, OBLN's ROE is -2.78%, compared to CERS's ROE of -0.26%. Regarding short-term risk, OBLN is more volatile compared to CERS. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check CERS's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, DCTH has a market cap of 322.4M. Regarding current trading prices, OBLN is priced at $3.05, while DCTH trades at $9.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas DCTH's P/E ratio is 132.57. In terms of profitability, OBLN's ROE is -2.78%, compared to DCTH's ROE of +0.03%. Regarding short-term risk, OBLN is more volatile compared to DCTH. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check DCTH's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, OBLN is priced at $3.05, while SMLR trades at $20.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas SMLR's P/E ratio is 3.92. In terms of profitability, OBLN's ROE is -2.78%, compared to SMLR's ROE of +0.16%. Regarding short-term risk, OBLN is more volatile compared to SMLR. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check SMLR's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, CATX has a market cap of 307.2M. Regarding current trading prices, OBLN is priced at $3.05, while CATX trades at $4.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas CATX's P/E ratio is -2.96. In terms of profitability, OBLN's ROE is -2.78%, compared to CATX's ROE of -0.41%. Regarding short-term risk, OBLN is more volatile compared to CATX. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check CATX's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, SENS has a market cap of 278.2M. Regarding current trading prices, OBLN is priced at $3.05, while SENS trades at $6.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas SENS's P/E ratio is -4.01. In terms of profitability, OBLN's ROE is -2.78%, compared to SENS's ROE of -1.04%. Regarding short-term risk, OBLN is more volatile compared to SENS. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check SENS's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, CLPT has a market cap of 270.7M. Regarding current trading prices, OBLN is priced at $3.05, while CLPT trades at $9.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas CLPT's P/E ratio is -10.11. In terms of profitability, OBLN's ROE is -2.78%, compared to CLPT's ROE of -1.22%. Regarding short-term risk, OBLN is more volatile compared to CLPT. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check CLPT's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, RXST has a market cap of 254.2M. Regarding current trading prices, OBLN is priced at $3.05, while RXST trades at $6.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas RXST's P/E ratio is -6.48. In terms of profitability, OBLN's ROE is -2.78%, compared to RXST's ROE of -0.14%. Regarding short-term risk, OBLN is more volatile compared to RXST. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check RXST's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, CVRX has a market cap of 248.9M. Regarding current trading prices, OBLN is priced at $3.05, while CVRX trades at $9.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas CVRX's P/E ratio is -4.64. In terms of profitability, OBLN's ROE is -2.78%, compared to CVRX's ROE of -0.99%. Regarding short-term risk, OBLN is more volatile compared to CVRX. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check CVRX's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, OBLN is priced at $3.05, while MGRM trades at $6.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas MGRM's P/E ratio is -11.11. In terms of profitability, OBLN's ROE is -2.78%, compared to MGRM's ROE of -1.37%. Regarding short-term risk, OBLN is more volatile compared to MGRM. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check MGRM's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, MASS has a market cap of 228.8M. Regarding current trading prices, OBLN is priced at $3.05, while MASS trades at $6.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas MASS's P/E ratio is -6.58. In terms of profitability, OBLN's ROE is -2.78%, compared to MASS's ROE of +0.13%. Regarding short-term risk, OBLN is more volatile compared to MASS. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check MASS's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, OBLN is priced at $3.05, while NVRO trades at $5.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas NVRO's P/E ratio is -1.91. In terms of profitability, OBLN's ROE is -2.78%, compared to NVRO's ROE of -0.27%. Regarding short-term risk, OBLN is more volatile compared to NVRO. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check NVRO's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, EYES has a market cap of 210M. Regarding current trading prices, OBLN is priced at $3.05, while EYES trades at $4.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas EYES's P/E ratio is N/A. In terms of profitability, OBLN's ROE is -2.78%, compared to EYES's ROE of -3.17%. Regarding short-term risk, OBLN is more volatile compared to EYES. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check EYES's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, ANIK has a market cap of 209.1M. Regarding current trading prices, OBLN is priced at $3.05, while ANIK trades at $14.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas ANIK's P/E ratio is -20.71. In terms of profitability, OBLN's ROE is -2.78%, compared to ANIK's ROE of -0.07%. Regarding short-term risk, OBLN is more volatile compared to ANIK. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check ANIK's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, AVR has a market cap of 204M. Regarding current trading prices, OBLN is priced at $3.05, while AVR trades at $5.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas AVR's P/E ratio is -2.17. In terms of profitability, OBLN's ROE is -2.78%, compared to AVR's ROE of -5.28%. Regarding short-term risk, OBLN is more volatile compared to AVR. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check AVR's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, SGHT has a market cap of 203.6M. Regarding current trading prices, OBLN is priced at $3.05, while SGHT trades at $3.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas SGHT's P/E ratio is -5.09. In terms of profitability, OBLN's ROE is -2.78%, compared to SGHT's ROE of -0.56%. Regarding short-term risk, OBLN is more volatile compared to SGHT. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check SGHT's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, PROF has a market cap of 196.1M. Regarding current trading prices, OBLN is priced at $3.05, while PROF trades at $6.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas PROF's P/E ratio is -4.60. In terms of profitability, OBLN's ROE is -2.78%, compared to PROF's ROE of -0.80%. Regarding short-term risk, OBLN is more volatile compared to PROF. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check PROF's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, ELMD has a market cap of 194.7M. Regarding current trading prices, OBLN is priced at $3.05, while ELMD trades at $24.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas ELMD's P/E ratio is 22.66. In terms of profitability, OBLN's ROE is -2.78%, compared to ELMD's ROE of +0.20%. Regarding short-term risk, OBLN is more volatile compared to ELMD. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check ELMD's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, OBLN is priced at $3.05, while BSGM trades at $6.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas BSGM's P/E ratio is -5.81. In terms of profitability, OBLN's ROE is -2.78%, compared to BSGM's ROE of +17.60%. Regarding short-term risk, OBLN is more volatile compared to BSGM. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check BSGM's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, OBLN is priced at $3.05, while MDGS trades at $2.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas MDGS's P/E ratio is -0.27. In terms of profitability, OBLN's ROE is -2.78%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, OBLN is more volatile compared to MDGS. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check MDGS's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, INGN has a market cap of 168.3M. Regarding current trading prices, OBLN is priced at $3.05, while INGN trades at $6.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas INGN's P/E ratio is -7.19. In terms of profitability, OBLN's ROE is -2.78%, compared to INGN's ROE of -0.12%. Regarding short-term risk, OBLN is more volatile compared to INGN. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check INGN's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, QTRX has a market cap of 165.2M. Regarding current trading prices, OBLN is priced at $3.05, while QTRX trades at $3.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas QTRX's P/E ratio is -1.40. In terms of profitability, OBLN's ROE is -2.78%, compared to QTRX's ROE of -0.35%. Regarding short-term risk, OBLN is more volatile compared to QTRX. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check QTRX's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, OBLN is priced at $3.05, while QIPT trades at $3.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas QIPT's P/E ratio is -15.87. In terms of profitability, OBLN's ROE is -2.78%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, OBLN is more volatile compared to QIPT. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check QIPT's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, QTI has a market cap of 159.3M. Regarding current trading prices, OBLN is priced at $3.05, while QTI trades at $6.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas QTI's P/E ratio is -2.92. In terms of profitability, OBLN's ROE is -2.78%, compared to QTI's ROE of +3.64%. Regarding short-term risk, OBLN is more volatile compared to QTI. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check QTI's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, APYX has a market cap of 154.3M. Regarding current trading prices, OBLN is priced at $3.05, while APYX trades at $3.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas APYX's P/E ratio is -13.67. In terms of profitability, OBLN's ROE is -2.78%, compared to APYX's ROE of -1.18%. Regarding short-term risk, OBLN is more volatile compared to APYX. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check APYX's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, TLSI has a market cap of 151.6M. Regarding current trading prices, OBLN is priced at $3.05, while TLSI trades at $4.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas TLSI's P/E ratio is -2.17. In terms of profitability, OBLN's ROE is -2.78%, compared to TLSI's ROE of +1.37%. Regarding short-term risk, OBLN is more volatile compared to TLSI. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check TLSI's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, SNWV has a market cap of 148.6M. Regarding current trading prices, OBLN is priced at $3.05, while SNWV trades at $17.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas SNWV's P/E ratio is 42.17. In terms of profitability, OBLN's ROE is -2.78%, compared to SNWV's ROE of -1.42%. Regarding short-term risk, OBLN is more volatile compared to SNWV. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check SNWV's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, NNOX has a market cap of 144.7M. Regarding current trading prices, OBLN is priced at $3.05, while NNOX trades at $2.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas NNOX's P/E ratio is -2.58. In terms of profitability, OBLN's ROE is -2.78%, compared to NNOX's ROE of -0.32%. Regarding short-term risk, OBLN is more volatile compared to NNOX. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check NNOX's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, EDAP has a market cap of 139.1M. Regarding current trading prices, OBLN is priced at $3.05, while EDAP trades at $3.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas EDAP's P/E ratio is -4.77. In terms of profitability, OBLN's ROE is -2.78%, compared to EDAP's ROE of -1.01%. Regarding short-term risk, OBLN is more volatile compared to EDAP. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check EDAP's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, LUCD has a market cap of 117.6M. Regarding current trading prices, OBLN is priced at $3.05, while LUCD trades at $1.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas LUCD's P/E ratio is -1.67. In terms of profitability, OBLN's ROE is -2.78%, compared to LUCD's ROE of -25.74%. Regarding short-term risk, OBLN is more volatile compared to LUCD. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check LUCD's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, FONR has a market cap of 114.6M. Regarding current trading prices, OBLN is priced at $3.05, while FONR trades at $18.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas FONR's P/E ratio is 16.14. In terms of profitability, OBLN's ROE is -2.78%, compared to FONR's ROE of +0.04%. Regarding short-term risk, OBLN is more volatile compared to FONR. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check FONR's competition here

OBLN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OBLN stands at 5.5M. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, OBLN is priced at $3.05, while ICAD trades at $3.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OBLN currently has a P/E ratio of -2.22, whereas ICAD's P/E ratio is -20.37. In terms of profitability, OBLN's ROE is -2.78%, compared to ICAD's ROE of -0.12%. Regarding short-term risk, OBLN is more volatile compared to ICAD. This indicates potentially higher risk in terms of short-term price fluctuations for OBLN.Check ICAD's competition here